Legal Opinion
Allergan, Inc. v. Barr Laboratories, Inc.
Court of Appeals for the Federal Circuit
Decided January 28, 2013No. 2012-1040, 2012-1054UnpublishedCited by 5 opinions
1Opinion of the Court
WALLACH, Circuit Judge.
Barr Laboratories, Inc., Teva Pharmaceuticals USA, Inc., and Teva Pharmaceutical Industries Ltd. (collectively, “Barr”), and Sandoz Inc. (“Sandoz”) appeal from the decision of the United States District Court for the District of Delaware, which held that Barr’s and Sandoz’s proposed products (described in Abbreviated New Drug Applications (“ANDA”) Nos. 91-194 and 200487, respectively) infringed claim 10 of Allergan, Inc.’s (“Allergan”) U.S. Patent No. 5,688,819 (“the '819 patent”) and that the asserted claim was not invalid. 1 Allergan, Inc. v. Barr Labs., Inc., 808…
2Cases cited14 opinions
- Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-CrossCourt of Appeals for the Federal Circuit · 2006
- Cybor Corporation v. Fas Technologies, Inc., and Fastar Ltd., Defendants-CrossCourt of Appeals for the Federal Circuit · 1998
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
- Union Carbide Corporation v. American Can CompanyCourt of Appeals for the Federal Circuit · 1984
9 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- In re Biogen 755 Patent Litig.District Court, D. New Jersey · 2018
- INVISTA North America S.à.r.l. v. M & G USA Corp.District Court, D. Delaware · 2013
- ASETEK Danmark A/S v. CMI USA, Inc.District Court, N.D. California · 2015
- Twist, Inc. v. B GSE Group, LLCDistrict Court, W.D. North Carolina · 2021
- Vectura Limited v. GlaxoSmithKline LLCDistrict Court, D. Delaware · 2019